| The Expansion of CD25highIL-10highFoxP3high B Regulatory Cells Is in Association with SLE Disease Activity Z Vadasz, R Peri, N Eiza, G Slobodin, A Balbir-Gurman, E Toubi Journal of immunology research 2015, 2015 | 55 | 2015 |
| Semaphorin 3A is effective in reducing both inflammation and angiogenesis in a mouse model of bronchial asthma SD Adi, N Eiza, J Bejar, H Shefer, S Toledano, O Kessler, G Neufeld, ... Frontiers in immunology 10, 550, 2019 | 28 | 2019 |
| Semaphorin-3A inhibits multiple myeloma progression in a mouse model N Lavi, O Kessler, K Ziv, I Nir-Zvi, Y Mumblat, N Eiza, Y Paran, B Brenner, ... Carcinogenesis 39 (10), 1283-1291, 2018 | 18 | 2018 |
| Low urine secretion of semaphorin3a in lupus patients with proteinuria R Doron, L Merav, E Nasrin, SD Adi, T Elias, S Gleb, R Itzhak, R Michael, ... Inflammation, 1-7, 2022 | 7 | 2022 |
| CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus N Eiza, AD Sabag, O Kessler, G Neufeld, Z Vadasz Journal of Autoimmunity 134, 102960, 2023 | 6 | 2023 |
| The expression of IL-17, in chronic spontaneous urticaria is linked to semaphorin5A M Lobna, E Nasren, S Adi, B Jacob, GAA Maria, M Marcus, V Zahava Biomolecules 11 (3), 373, 2021 | 5 | 2021 |
| Increased killer B cells in chronic HCV infection may lead to autoimmunity and increased viral load N Eiza, E Zuckerman, M Carlebach, T Rainis, Y Goldberg, Z Vadasz Clinical & Experimental Immunology 193 (2), 183-193, 2018 | 5 | 2018 |
| Increased T and B regulatory cell function contributes to the persistence of HCV and other viral infections N Eiza, E Toubi, Z Vadasz Isr Med Assoc J 18 (3-4), 159-161, 2016 | 5 | 2016 |
| The possible involvement of sema3A and sema4A in the pathogenesis of multiple sclerosis N Eiza, M Garty, E Staun-Ram, A Miller, Z Vadasz Clinical Immunology 238, 109017, 2022 | 4 | 2022 |
| The association between semaphorin 3A levels and gluten-free diet in patients with celiac disease A Kessel, C Lin, Z Vadasz, R Peri, N Eiza, D Berkowitz Clinical Immunology 184, 73-76, 2017 | 4 | 2017 |
| Truncated-semaphorin3A is a potential regulatory molecule to restore immune homeostasis in immune-mediated diseases N Eiza, O Kessler, A Sabag, G Neufeld, EY Jones, Z Vadasz Frontiers in Pharmacology 13, 1085892, 2023 | 2 | 2023 |
| AB0189 decreased urine semaphorin 3A secretion predicts the extent of renal damage in systemic lupus erythematosus patients D Rimar, M Lidar, N Eiza, E Toubi, A Silawy, G Slobodin, I Rosner, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 1551-1552, 2019 | 1 | 2019 |
| The Involvement of LAG-3positive Plasma Cells in the Development of Multiple Myeloma N Kreiniz, N Eiza, T Tadmor, I Levy Yurkovski, S Matarasso Greenfeld, ... International Journal of Molecular Sciences 25 (1), 549, 2023 | | 2023 |
| Soluble LAG3: A Potential Marker for the Development and Activity of Acute Graft-Versus-Host Disease D Yehudai-Ofir, N Eiza, IJ Henig, T Zuckerman, Z Vadasz Blood 142, 4795, 2023 | | 2023 |
| CD72-semaphorin3A axis; a possible new player in immune regulation E Nasren, SD Adi, K Ofra, J Yunens, N Gera, V Zahava bioRxiv, 2021.08. 24.457482, 2021 | | 2021 |
| Increased killer B cells: are they associated with increased viral load and autoimmunity in patients with chronic hepatitis C virus infection? E Zuckerman, N Eiza, M Carlebach, T Rainess, Y Goldberg, E Toubi, ... Journal of Hepatology 1 (66), S330, 2017 | | 2017 |
